» Articles » PMID: 34124629

After the Initial Fracture in Postmenopausal Women, Where Do Subsequent Fractures Occur?

Overview
Specialty General Medicine
Date 2021 Jun 14
PMID 34124629
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The locations of subsequent fractures after initial fracture in postmenopausal women are poorly characterized.

Methods: We conducted a prospective analysis of subsequent fractures after initial fracture in Women's Health Initiative (1993-2018) participants who provided follow-up (mean 15.4 years, SD 6.2 years) data ( = 157,282 participants; baseline age 50-79; 47,458 participants with incident fracture). Cox proportional hazards models were adjusted for age, race/ethnicity, body mass index, and other covariates.

Findings: The risk of each type of subsequent fracture was increased after each type of initial fracture. Incident lower arm/wrist fracture was associated with significantly elevated risks of subsequent fractures at the upper arm/shoulder, upper leg, knee, lower leg/ankle, hip/pelvis, and spine (adjusted hazard ratios [aHRs] ranging 2·63-5·68). The risk of hip fracture was increased after initial lower arm or wrist fracture (aHR 4·80, 95% CI 4·29-5·36), initial upper arm or shoulder fracture (aHR 5·06, 95% CI 4·39-5·82), initial upper leg fracture (aHR 5·11, 95% CI 3·91-6·67), initial knee fracture (aHR 5·03, 95% CI 4·20-6·03), initial lower leg/ankle fracture (aHR 4·10, 95% CI 3·58-4·68), and initial spine fracture (aHR 6·69, 95% CI 5·95-7·53). Associations were significant in all age groups, even women aged 50-59 years. Risks of subsequent fracture were more pronounced among non-Hispanic Black, Hispanic/Latina, and Asian/Pacific Islander than among non-Hispanic White women.

Interpretation: Increased risk of subsequent fracture is observed for all fracture types across all ages. Women who experience any of these fractures should be targeted for interventions to prevent subsequent fractures.

Funding: National Institutes of Health HHSN268201600018C,HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C.

Citing Articles

Hospitalizations for hip and non-hip osteoporotic fractures in Belgium: nationwide trends between 2010 and 2021.

Janssens S, Gielen E, Laurent M, Sermon A, Herteleer M, Dejaeger M Arch Osteoporos. 2024; 19(1):62.

PMID: 39034383 DOI: 10.1007/s11657-024-01423-1.


Using In-Shoe Inertial Measurement Unit Sensors to Understand Daily-Life Gait Characteristics in Patients With Distal Radius Fractures During 6 Months of Recovery: Cross-Sectional Study.

Yamamoto A, Yamada E, Ibara T, Nihey F, Inai T, Tsukamoto K JMIR Mhealth Uhealth. 2024; 12:e55178.

PMID: 38506913 PMC: 10993120. DOI: 10.2196/55178.


Editorial: Advances in comprehensive treatment of postmenopausal osteoporotic fractures.

Endo Y, Weber L, Mroueh J Front Med (Lausanne). 2024; 11:1378312.

PMID: 38414616 PMC: 10897035. DOI: 10.3389/fmed.2024.1378312.


Associations of Quantitative and Qualitative Muscle Parameters With Second Hip Fracture Risk in Older Women: A Prospective Cohort Study.

Zhang W, Ge Y, Liu Y, Yuan Y, Geng J, Zhou F JBMR Plus. 2023; 7(12):e10834.

PMID: 38130767 PMC: 10731097. DOI: 10.1002/jbm4.10834.


Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.

Kanis J, Johansson H, McCloskey E, Liu E, Akesson K, Anderson F Osteoporos Int. 2023; 34(12):2027-2045.

PMID: 37566158 PMC: 7615305. DOI: 10.1007/s00198-023-06870-z.


References
1.
Curry S, Krist A, Owens D, Barry M, Caughey A, Davidson K . Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMA. 2018; 319(24):2521-2531. DOI: 10.1001/jama.2018.7498. View

2.
. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998; 19(1):61-109. DOI: 10.1016/s0197-2456(97)00078-0. View

3.
Wysowski D, Greene P . Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012. Bone. 2013; 57(2):423-8. DOI: 10.1016/j.bone.2013.09.008. View

4.
Desai R, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D . Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. JAMA Netw Open. 2019; 1(3):e180826. PMC: 6324295. DOI: 10.1001/jamanetworkopen.2018.0826. View

5.
Langer R, White E, Lewis C, Kotchen J, Hendrix S, Trevisan M . The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003; 13(9 Suppl):S107-21. DOI: 10.1016/s1047-2797(03)00047-4. View